CD8A and neoplasm: The most effective treatments, i.e., IMDQ-PEG-cholesteryl and OxPt-PEG-cholesteryl + IMDQ-PEG-cholesteryl, also elicited an increased AH1-specific anti-tumor response, demonstrated by an increase in the tumor infiltration of AH1+/CD8+ T cells.